124
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Effect of Norcantharidin on the Human Breast Cancer Bcap-37 Cells

, , , &
Pages 508-512 | Received 17 Jan 2012, Accepted 15 May 2012, Published online: 20 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Liya Zeng & Yalin Zhang. (2017) Development, optimization and in vitro evaluation of norcantharidin loadedself-nanoemulsifying drug delivery systems (NCTD-SNEDDS). Pharmaceutical Development and Technology 22:3, pages 399-408.
Read now
Kun Ye, Qiaoyu Wei, Zhifeng Gong, Yunfeng Huang, Hong Liu, Ying Li & Xiaomei Peng. (2017) Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells. Renal Failure 39:1, pages 458-464.
Read now
Omar F. Khabour, Fatima M. Enaya, Karem Alzoubi & Sayer I. Al-Azzam. (2016) Evaluation of DNA damage induced by norcantharidin in human cultured lymphocytes. Drug and Chemical Toxicology 39:3, pages 303-306.
Read now

Articles from other publishers (10)

Xiaoyan Zhu, Xiaohong Chen, Longshan Qiu, Jianhua Zhu & Jiancai Wang. (2022) Norcantharidin induces ferroptosis via the suppression of NRF2/HO‑1 signaling in ovarian cancer cells. Oncology Letters 24:4.
Crossref
Chaochao Yu, Yi Li, Guopeng Chen, Chaoyan Wu, Xiuping Wang & Yingwen Zhang. (2022) Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges动物来源中药活性组分在乳腺癌中的运用: 机遇和挑战. Journal of Zhejiang University-SCIENCE B 23:7, pages 547-563.
Crossref
Ragini Singh, Shuang Cheng, Jun Li, Santosh Kumar, Qinghua Zeng & Qingmei Zeng. (2021) Norcantharidin combined with 2-deoxy-d-glucose suppresses the hepatocellular carcinoma cells proliferation and migration. 3 Biotech 11:3.
Crossref
Mu-Su Pan, Jin Cao & Yue-Zu Fan. (2020) Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities. Chinese Medicine 15:1.
Crossref
Qiang He, Shuyin Xue, Yiqing Tan, Ling Zhang, Qing Shao, Lei Xing, Yunhai Li, Tingxiu Xiang, Xinrong Luo & Guosheng Ren. (2019) Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer. Cancer Letters 448, pages 94-104.
Crossref
Imad S. KhanMitchell OdomMoneeb EhteshamDaniel Colvin, C. Chad Quarles, BethAnn McLaughlin & Robert J. Singer. (2016) Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities. Journal of Neurosurgery 125:1, pages 152-159.
Crossref
Dajiang Xie, Jixi Xie, Yingfeng Wan, Li Ma, Xuchen Qi, Kun Wang & Shuxu Yang. (2016) Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma. Oncology Reports.
Crossref
Junran Xie, Yaping Zhang, Xuming Hu, Ran Lv, Dongju Xiao, Li Jiang & Qi Bao. (2015) Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer. Medical Oncology 32:5.
Crossref
Surya B. Prasad & Akalesh K. Verma. (2013) Cantharidin-Mediated Ultrastructural and Biochemical Changes in Mitochondria Lead to Apoptosis and Necrosis in Murine Dalton's Lymphoma. Microscopy and Microanalysis 19:6, pages 1377-1394.
Crossref
Akalesh Kumar Verma & Surya Bali Prasad. (2013) Antitumor effect of blister beetles: An ethno-medicinal practice in Karbi community and its experimental evaluation against a murine malignant tumor model. Journal of Ethnopharmacology 148:3, pages 869-879.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.